Kratom Research Institute

Policy · 2026-07-01

American Kratom Association: DEA Scheduling Proves Natural Kratom and Synthetic 7-OH Are Fundamentally Different

Source: American Kratom Association

Why it matters

The nation's primary kratom advocacy organization argues the DEA's scheduling action draws an official federal line between natural botanical kratom and chemically engineered 7-OH opioid products — a distinction that could determine whether millions of kratom users keep legal access to the plant.

The big picture

As federal and state regulators move to restrict concentrated 7-OH, the mainstream kratom industry is positioning itself as an ally of targeted regulation, not its victim. The AKA's public support for DEA's action reframes the entire debate heading into the 30-day public comment period: banning 7-OH is separate from banning kratom, and treating them identically would harm responsible adult consumers while rewarding bad actors who created the synthetic opioid crisis.

Key findings

What they say

"Do not ban kratom because of 7-OH. Ban 7-OH because it is not kratom." — Mac Haddow, Senior Fellow on Public Policy, American Kratom Association

Bottom line

The AKA backing of the DEA scheduling action argues that a precisely targeted federal rule can clear dangerous semi-synthetic products from the market while preserving legal access to botanical kratom — a distinction the 30-day public comment period will either reinforce or undermine.